Veterinary Medicines

PermaWay 600 mg intramammary suspension for cattle

Authorised
  • Cloxacillin benzathine
Download as PDF

Product identification

Medicine name:
Permaway 600 mg suspensão intramamária para bovinos
PermaWay 600 mg intramammary suspension for cattle
Active substance:
  • Cloxacillin benzathine
Target species:
  • Cattle (dry cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cloxacillin benzathine
    765.40
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (dry cow)
      • Meat and offal
        28
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51CF02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • box containing 96 intramammary syringes
  • box containing 48 intramammary syringes
  • box containing 24 intramammary syringes

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol Unipessoal Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol Biowet Sp. z o.o.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 1376/01/20DFVPT
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0384/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 22/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."